Skip to content
Get alerts
GovInfoNow
Lower risk Drug recall · FDA · Published August 28, 2019

Atlas Pharmaceuticals Ascorbic Acid Injection Recall: Non-Corn Labeling Error

Atlas Pharmaceuticals recalls sterile ascorbic acid injection solution due to incorrect "Non-Corn Source" labeling. The product is actually corn-derived. No action needed per recall details.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #D-0144-2020DrugAtlas Pharmaceuticals ›
Take action

Contact the company

Recalling firmAtlas Pharmaceuticals, LLC711 E Carefree Hwy Ste 107 · Phoenix, AZ 85085-0103
✎ GovInfoNow plain-language explainer

Atlas Pharmaceuticals is recalling a specific ascorbic acid injection solution because its label incorrectly states it's non-corn sourced when it's actually corn-based. This labeling error doesn't pose a safety risk to patients but requires correction for regulatory compliance. Read more at govinfonow.com/recall/38067-atlas-pharmaceuticals-ascorbic-acid-injection-recall-non-corn-labeling-error.

Source Summary by GovInfoNow · govinfonow.com/recall/38067-atlas-pharmaceuticals-ascorbic-acid-injection-recall-non-corn-labeling-error · Updated October 5, 2026 · FDA enforcement record: FDA #D-0144-2020

Cite this page

“Atlas Pharmaceuticals Ascorbic Acid Injection Recall: Non-Corn Labeling Error.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/38067-atlas-pharmaceuticals-ascorbic-acid-injection-recall-non-corn-labeling-error. Based on FDA recall #D-0144-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0144-2020%22&limit=1).

The FDA announced on August 28, 2019, that Atlas Pharmaceuticals, LLC is recalling Ascorbic Acid Sterile Injection Solution because the product is labeled as a non-corn source when it is derived from corn. The recall affects 1,646 vials distributed to healthcare facilities in Arizona and Colorado.

How to tell if you have it

  • Brand: Atlas Pharmaceuticals
  • Product: Ascorbic Acid Sterile Injection Solution, 500 mg/mL, 50 mL vial
  • NDC: 71591-500-50
  • Lot codes: S-60162 (BUD 10/12/2019), S-60176 (BUD 11/2/2019), S-60187 (BUD 11/11/2019), S-60189 (BUD 11/16/2019), S-60190 (BUD 11/16/2019), S-60222 (BUD 01/20/2020)
  • Distribution: Healthcare facilities/clinics in AZ and CO
  • Quantity: 1,646 vials

The hazard

The product is labeled as "Non-Corn Source" but is actually from a corn source. This labeling error constitutes the hazard for this Class II recall.

Context

GovInfoNow's records show other recent recalls of similar products include Slate Run Recalls Eptifibatide Injection Due to Labeling Error (2026-02-12) and American Regent Levocarnitine Injection Recall: Missing Label Hazard (2026-04-16).

How to tell if you have this one

Check the product label for the lot numbers: S-60162 (BUD 10/12/2019), S-60176 (BUD 11/2/2019), S-60187 (BUD 11/11/2019), S-60189 (BUD 11/16/2019), S-60190 (BUD 11/16/2019), or S-60222 (BUD 01/20/2020).

  • Brand
    Atlas Pharmaceuticals
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Label

    Look for the lot numbers listed in the recall notice to confirm if your product is affected.

Where it went and when

Where it was distributed

Distributed in Arizona and Colorado.

Alaska: not listedAKMaine: not listedMEVermont: not listedVTNew Hampshire: not listedNHWashington: not listedWAIdaho: not listedIDMontana: not listedMTNorth Dakota: not listedNDMinnesota: not listedMNIllinois: not listedILWisconsin: not listedWIMichigan: not listedMINew York: not listedNYRhode Island: not listedRIMassachusetts: not listedMAOregon: not listedORNevada: not listedNVWyoming: not listedWYSouth Dakota: not listedSDIowa: not listedIAIndiana: not listedINOhio: not listedOHPennsylvania: not listedPANew Jersey: not listedNJConnecticut: not listedCTCalifornia: not listedCAUtah: not listedUTColorado: yesCONebraska: not listedNEMissouri: not listedMOKentucky: not listedKYWest Virginia: not listedWVVirginia: not listedVAMaryland: not listedMDDelaware: not listedDEArizona: yesAZNew Mexico: not listedNMKansas: not listedKSArkansas: not listedARTennessee: not listedTNNorth Carolina: not listedNCSouth Carolina: not listedSCDistrict of Columbia: not listedDCOklahoma: not listedOKLouisiana: not listedLAMississippi: not listedMSAlabama: not listedALGeorgia: not listedGAHawaii: not listedHITexas: not listedTXFlorida: not listedFL

FDA distribution: “Healthcare facilities/clinics in AZ and CO” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: Arizona, Colorado.

Recall timeline

FDA terminated this recall 9 months after the firm started it.

1. Firm started the recall: Aug 28, 201912. FDA classified it Class II: Oct 15, 201923. Published in FDA’s Enforcement Report: Oct 23, 201934. FDA terminated the recall: Jun 3, 2020420192020
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

From the GovInfoNow team · based on the FDA notice · How we make summaries

Do I need to stop using this product?

No action is required as the labeling error does not affect safety. The product can be used as normal.

Similar recalls

Preferred Pharma Recalls Lidocaine Ointment Due to Content Issues
Preferred Pharmaceuticals, Inc.Northstar Rx Recalls Tretinoin Cream Due to Impurities
SUN PHARMACEUTICAL INDUSTRIES INCApothecary Pharma Recalls Tirzepatide Injections Due to Sterility Risk
Apothecary Pharma LLCApotex Recalls Paroxetine 37.5mg Due to Dissolution Failure
Apotex Corp.Cipla Recalls Fosfomycin Tromethamine Granules Due to Impurities
Cipla USA, Inc.

Latest drug recalls

Ajanta Pharma USA Inc recalls Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle, Rx Only, Marketed by: Ajanta Pharma USA Inc.,
Ajanta Pharma · September 17, 2026Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company recalls Clear Eyes Redness Relief, Lubricant/Redness Reliever Eye Drops (glycerin 0.25%, naphazoline hydrochloride 0.012%) with
Insight Pharmaceuticals · September 15, 2026K.C. Pharmaceuticals, Inc. recalls Sterile Lubricant Dry Eye Relief Eye Drops, 0.5 FL OZ (15 mL); a) LEADER, DISTRIBUTED BY CARDINAL HEALTH, DUBLIN, OHIO
Leader / TopCare / Crocodile Tears · September 11, 2026Amneal Pharmaceuticals, LLC recalls Estradiol Gel, 0.1%, 0.25 mg, 30-packets per carton, Rx only, Distributed by: Amneal Pharmaceuticals LLC, Bridgewater,
Amneal Pharmaceuticals · September 8, 2026Inventia Healthcare Limited recalls Chlorthalidone Tablets, USP, 25 mg, 100 Tablets per bottle, Rx only, Manufactured by: Inventia Healthcare Limited. NDC:
Inventia Healthcare · September 3, 2026SV Labs Toronto Corporation recalls Benzoyl Peroxide Wash, USP, 10%, packaged in a)5 FL OZ (148mL) bottles (NDC 0536-1261-63), and b) 8.5 FL OZ (237 mL)
SV Labs · September 1, 2026

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0144-2020 (August 28, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0144-2020 to see it in context.
  • Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA